Steris CorporationMarch 31, 2022

FDA 483 - Steris Corporation - March 31, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

An FDA inspection of Carefusion 2200 Inc in Saint Louis, MO, revealed a significant lapse in quality system procedures. The firm failed to establish procedures for finished device acceptance, leading to products not being properly identified or quarantined. This indicates a moderate compliance issue related to device control.

Company: Steris Corporation
Inspection Date: March 31, 2022
Product Type: Device
Office: Division of Human and Animal Food Operations - West II
Person: Clifford F. Long

Open in Dashboard

ID · 9ae203c3-7b01-4f91-8c77-9527180af18d